meta
|
evidence
oncology
Living systematic review and meta-analysis
metastatic/advanced OC (mOC) - maintenance (M)
2
pancreatic ductal adenocarcinoma
PIK3CA-related overgrowth spectrum
prostate cancer (PC)
endocrine therapy
androgen deprivation therapy (ADT)
abiraterone plus ADT
abiraterone plus docetaxel plus ADT
apalutamide plus ADT
darolutamide plus doxetaxel plus ADT
docetaxel plus ADT
enzalutamide
enzalutamide plus ADT
immune chekpoint inhibitors
anti-CTLA-4
ipilimumab based treatment
ipilimumab alone
anti-PD-(L)1
pembrolizumab based treatment
versus all
vs chemotherapy
vs endocrine therapy
vs androgen deprivation therapy (ADT)
vs docetaxel plus ADT
vs non active control
vs placebo
All patients
Top evidence (RCT only, high risk of bias excluded)
Best available evidence (possibly low or very low)
All RCTs
All studies (RCT+OBS)
study list
mapping
overview
meta-analysis
forest plot
NMA
excluded
button
bars
forest
bayes
pooled
summary
circles
deaths (OS)
deaths (OS)
metastatic (mCRPC) - 1st line (L1)
castration-resistant prostate cancer (CRPC)
metastatic (mCRPC) - 1st line (L1)
metastatic, hormone-sensitive prostate cancer
metastatic, hormone-sensitive prostate cancer
versus androgen deprivation therapy (ADT)
abiraterone plus ADT vs. androgen deprivation therapy (ADT)
2
0.63
[0.54; 0.72], 2 RCTs, I2=0%
conclusive
unassessable degree of certainty
apalutamide plus ADT vs. androgen deprivation therapy (ADT)
1
0.67
[0.51; 0.89], 1 RCT, I2=0%
conclusive
unassessable degree of certainty
docetaxel plus ADT vs. androgen deprivation therapy (ADT)
4
0.76
[0.64; 0.90], 4 RCTs, I2=54%
conclusive
unassessable degree of certainty
enzalutamide plus ADT vs. androgen deprivation therapy (ADT)
2
0.66
[0.56; 0.78], 2 RCTs, I2=0%
unassessable degree of certainty
versus docetaxel plus ADT
abiraterone plus docetaxel plus ADT vs. docetaxel plus ADT
1
0.75
[0.59; 0.95], 1 RCT, I2=0%
conclusive
unassessable degree of certainty
darolutamide plus doxetaxel plus ADT vs. docetaxel plus ADT
1
0.68
[0.57; 0.81], 1 RCT, I2=0%
conclusive
unassessable degree of certainty
×
delta: difference in rate or median (if available)
×
Extraction panel open
An extraction panel is open